Advertisement
News
Subscribe to MDT Magazine News

New Material For Surgical Products Could Aid In Healing Process

July 30, 2014 11:03 am | by McCormick School of Engineering and Applied Science | Comments

When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.

Researchers identify potential biomarker for AD

July 30, 2014 10:55 am | by EurekAlert! | Comments

Researchers from Boston University School of Medicine (BUSM) report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically. These findings appear in the Annals of Neurology.

App for headache sufferers shows success

July 30, 2014 10:21 am | by EurekAlert! | Comments

A unique app that helps headache sufferers to record the severity and regularity of their pain is being used as part of a Griffith research study. A new approach to the treatment of headaches, the ENHANCE project looks at coping with their triggers and is

TOPICS:
Advertisement

Wearable device for the early detection of common diabetes-related neurological condition

July 30, 2014 9:57 am | by EurekAlert! | Comments

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.

TOPICS:

Tigermed and Frontage Laboratories Complete Strategic Investment Agreement

July 30, 2014 9:35 am | by The Associated Press | Comments

EXTON, Pa.--(BUSINESS WIRE)--Jul 30, 2014--Hangzhou Tigermed Consulting Co., Ltd. and Frontage Laboratories, Inc. today announced completion of the previously announced investment agreement, following approval by the China Securities and Regulatory Commission. Tigermed, a leading provider of...

BIOLASE Sends Letter to Stockholders

July 30, 2014 9:35 am | by The Associated Press | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Jul 30, 2014--BIOLASE, Inc. (NASDAQ:BIOL), the world’s leading dental laser manufacturer and distributor, today sent a letter to its stockholders. The full text of the letter from the majority of the Board to stockholders is below: To Our Fellow...

Report: Biopharma and Medical Device Companies Beat Historic Investment Returns

July 30, 2014 8:39 am | by PR Newswire | Comments

SANTA CLARA, Calif., July 30, 2014 /PRNewswire/ -- Silicon Valley Bank, the bank of the global innovation economy, released a study today that examines the merger, acquisition and IPO activity of private, venture-backed biopharma and medical device companies.  According to the annual...

Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD

July 30, 2014 7:28 am | by PR Newswire | Comments

MIAMI, July 30, 2014 /PRNewswire/ -- Medical Equipment Solutions, Corp. are pleased to announce that they have been awarded a Department of Defense (US Army) contract valued at over $2 million over 30 months to supply a mobile MRI diagnostic machine and technical support staffing. As...

Advertisement

NIH Awards Imbed Bio a $1.5M Grant to Develop Advanced Wound Healing Nanofilm

July 29, 2014 7:32 pm | by The Associated Press | Comments

MADISON, Wis.--(BUSINESS WIRE)--Jul 29, 2014--Imbed Biosciences, Inc, a medical device company developing advanced materials for wound healing and surgical applications, announced today that it has been awarded a $1.5M competitive Small Business Innovation Research (SBIR) Phase II grant from...

Potential 'universal' blood test for cancer discovered

July 29, 2014 3:10 pm | by EurekAlert! | Comments

Researchers from the University of Bradford, UK, have devised a simple blood test that can be used to diagnose whether people have cancer or not. The test will enable doctors to rule out cancer in patients presenting with certain symptoms, saving time and preventing costly and unnecessary invasive procedures such as ...

TOPICS:

CareDx Presents Cell-Free DNA Biomarker Results in Heart and Kidney Transplant Recipients

July 29, 2014 2:49 pm | by Globe Newswire | Comments

CareDx, Inc. announced the results of its cohort studies of blood samples from the multicenter CARGO and CARGO II heart transplant observational studies, and from the KARGO kidney transplant study during a presentation today at The World Transplant Congress in San Francisco, CA.

Health law expert: Under-regulated 'mHealth' industry could create 'Wild West' market

July 29, 2014 2:41 pm | by EurekAlert! | Comments

Smart phones and mobile devices are on the cusp of revolutionizing health care, armed with mobile health ("mHealth") apps capable of providing everything from cardiac measurements to sonograms. While tremendous potential exists to broaden access to medical treatment and control costs, several health law experts say in a just-published New England Journal of Medicine (NEJM) report that more oversight is needed by ...

Glucose 'control switch' in the brain key to both types of diabetes

July 29, 2014 2:32 pm | by EurekAlert! | Comments

Researchers at Yale School of Medicine have pinpointed a mechanism in part of the brain that is key to sensing glucose levels in the blood, linking it to both type 1 and type 2 diabetes. The findings are published in the July 28 issue of Proceedings of the National Academies of Sciences.

TOPICS:

Study helps compare risks of treatments for early esophageal cancer

July 29, 2014 2:13 pm | by EurekAlert! | Comments

A new study, published in the July, 2014, issue of the Journal of the National Cancer Institute by Northwestern Medicine® researchers, sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer. Researchers found that ...

TOPICS:

Medtronic Receives FDA Approval for PRESTIGE LP Cervical Disc System

July 29, 2014 2:02 pm | by Medtronic, Inc. | Comments

Medtronic, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System for the treatment of single-level cervical disc disease (radiculopathy and/or myelopathy). The PRESTIGE® LP Cervical Disc is the third clinically proven artificial cervical disc in the Medtronic portfolio and ...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading